Lonza Group reported 3.11B in Current Liabilities for its first fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Akzo Nobel AKZA:NA € 4407M 557M
Alcon AG ALC:SW 2.38B 172M
AstraZeneca AZN:LN 23649M 1427M
BASF BAS:GR € 20322M 788M
Bayer BAYN:GR € 28727M 801M
Covestro 1COV:GR 3.16B 251M
DSM DSM:NA € 2264M 82M
Fresenius FRE:GR € 15352M 148M
Fresenius Medical Care FME:GR € 7492M 67.37M
Genmab GEN:DC DK 1830M 479M
Givaudan GIVN:VX 2.41B 618M
GlaxoSmithKline GSK:LN 22417M 1030M
GN Store Nord GN:DC DK 4969M 394M
H. Lundbeck A/S LUN:DC 9.08B 646M
Hikma Pharmaceutical HIK:LN 960M 68M
Johnson Matthey JMAT:LN 3.58B 21M
Merck MRK:GR € 9793M 27M
Novartis NOVN:VX SF 29880M 247M
Solvay SOLB:BB € 4674M 1389M
William Demant Holding WDH:DC 9.47B 2.1B